Personalis Management

Management criteria checks 2/4

Personalis' CEO is Chris Hall, appointed in Dec 2022, has a tenure of 1.92 years. total yearly compensation is $1.73M, comprised of 30.9% salary and 69.1% bonuses, including company stock and options. directly owns 0.31% of the company’s shares, worth $765.81K. The average tenure of the management team and the board of directors is 3.3 years and 2.5 years respectively.

Key information

Chris Hall

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage30.9%
CEO tenure1.9yrs
CEO ownership0.3%
Management average tenure3.3yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

The Proper Play On Personalis

Oct 28

Investors Still Aren't Entirely Convinced By Personalis, Inc.'s (NASDAQ:PSNL) Revenues Despite 28% Price Jump

Sep 14
Investors Still Aren't Entirely Convinced By Personalis, Inc.'s (NASDAQ:PSNL) Revenues Despite 28% Price Jump

A Piece Of The Puzzle Missing From Personalis, Inc.'s (NASDAQ:PSNL) 131% Share Price Climb

Jul 25
A Piece Of The Puzzle Missing From Personalis, Inc.'s (NASDAQ:PSNL) 131% Share Price Climb

Market Cool On Personalis, Inc.'s (NASDAQ:PSNL) Revenues Pushing Shares 25% Lower

Apr 19
Market Cool On Personalis, Inc.'s (NASDAQ:PSNL) Revenues Pushing Shares 25% Lower

Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 31% Yet They're Still Not Telling The Full Story

Mar 02
Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 31% Yet They're Still Not Telling The Full Story

Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 37% Yet They're Still Not Telling The Full Story

Dec 18
Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 37% Yet They're Still Not Telling The Full Story

Will Personalis (NASDAQ:PSNL) Spend Its Cash Wisely?

Dec 04
Will Personalis (NASDAQ:PSNL) Spend Its Cash Wisely?

Personalis (NASDAQ:PSNL) Will Have To Spend Its Cash Wisely

Sep 04
Personalis (NASDAQ:PSNL) Will Have To Spend Its Cash Wisely

Investors Holding Back On Personalis, Inc. (NASDAQ:PSNL)

Apr 17
Investors Holding Back On Personalis, Inc. (NASDAQ:PSNL)

The Prognosis For Personalis

Jun 16

Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?

Jun 09
Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?

Is Personalis (NASDAQ:PSNL) Using Debt In A Risky Way?

Feb 17
Is Personalis (NASDAQ:PSNL) Using Debt In A Risky Way?

Personalis: Getting Personal Again

Feb 02

CEO Compensation Analysis

How has Chris Hall's remuneration changed compared to Personalis's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$91m

Jun 30 2024n/an/a

-US$81m

Mar 31 2024n/an/a

-US$93m

Dec 31 2023US$2mUS$534k

-US$108m

Sep 30 2023n/an/a

-US$113m

Jun 30 2023n/an/a

-US$110m

Mar 31 2023n/an/a

-US$114m

Dec 31 2022US$2mUS$83k

-US$113m

Compensation vs Market: Chris's total compensation ($USD1.73M) is about average for companies of similar size in the US market ($USD1.46M).

Compensation vs Earnings: Chris's compensation has increased whilst the company is unprofitable.


CEO

Chris Hall (55 yo)

1.9yrs

Tenure

US$1,726,790

Compensation

Mr. Christopher M. Hall, also known as Chris, served as Senior Vice President and Head of Diagnostics Business at Personalis, Inc. since October 2022 until December 31, 2022 and serves as its President sin...


Leadership Team

NamePositionTenureCompensationOwnership
Christopher Hall
President1.9yrsUS$1.73m0.31%
$ 765.8k
Aaron Tachibana
CFO & COO5.7yrsUS$1.67m0.27%
$ 664.1k
Stephen Moore
Senior VP & Chief Legal Officer4.6yrsUS$674.28k0.12%
$ 297.0k
Richard Chen
Executive VP of R&D and Chief Medical Officer3.3yrsUS$1.28m0.19%
$ 457.5k
Russ Altman
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Euan Ashley
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Michael Snyder
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Michael Fitzpatrick
Vice President of Worldwide Sales11.6yrsno datano data
Christian Haudenschild
Senior Vice President of Genomic Laboratory Operations3.2yrsno datano data
Stephane Mouradian
Senior Vice President of Business Development1.8yrsno datano data
Deepshikha Bhandari
Senior Vice President of Regulatory1.1yrsno datano data

3.3yrs

Average Tenure

53yo

Average Age

Experienced Management: PSNL's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Christopher Hall
President1.7yrsUS$1.73m0.31%
$ 765.8k
Russ Altman
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Euan Ashley
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Michael Snyder
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Kenneth Widder
Independent Director1.4yrsUS$154.00kno data
Karin Eastham
Independent Chair of the Board5.2yrsUS$173.05k0.024%
$ 58.1k
Arthur Bowman
Independent Director5.5yrsUS$121.38k0.024%
$ 58.1k
Woodrow Myers
Independent Director3.7yrsUS$108.88k0.046%
$ 112.3k
John West
Advisor to the Board1.9yrsUS$5.62mno data
Lonnie Shoff
Independent Director2.3yrsUS$103.88k0.018%
$ 44.3k
Olivia Bloom
Independent Director2.7yrsUS$116.38k0.031%
$ 75.7k

2.5yrs

Average Tenure

67yo

Average Age

Experienced Board: PSNL's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.